White Paper: Treating Pancreatic Tumors Without Invasive Surgery – Experts Weigh In | Newswise
Pancreatic cancer remains one of the most challenging cancers to treat, with limited treatment options and poor survival rates. However, a new white paper from the Focused Ultrasound Foundation highlights how focused ultrasound—a noninvasive, therapeutic technology—is emerging as a promising tool to improve outcomes for patients.
This white paper summarizes key insights from a recent international workshop of leading experts in pancreatic cancer treatment. It explores how focused ultrasound and histotripsy can:
- Enhance drug delivery by disrupting tumor barriers to improve chemotherapy and immunotherapy effectiveness
- Reduce pain and improve quality of life for patients with inoperable tumors
- Potentially ablate tumors outright, offering a noninvasive alternative to surgery and radiation
Clinical trials using focused ultrasound for pancreatic cancer are already underway at institutions including Virginia Tech, the University of Virginia, Brigham and Women’s Hospital, Seoul National University Hospital, Oxford, and Bonn.
Experts at the Foundation would be happy to share more details or connect you with the principal investgators of these studies who can discuss the latest research and clinical applications.
